Brief: Astrazeneca Pharma India And Sun Pharma Partner For Hyperkalaemia Treatment
17/11/2025 11:12
Nov 17 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: ASTRAZENECA PHARMA INDIA LTD - CO AND SUN PHARMA PARTNER FOR HYPERKALAEMIA TREATMENT ASTRAZENECA PHARMA INDIA LTD - TO MARKET SZC AS LOKELMA, SUN PHARMA AS GIMLIAND ASTRAZENECA PHARMA INDIA LTD - TO RECEIVE 260 MILLION RUPEES FROM SUN PHARMA Source text: ID:nBSE4CSNbq Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication